Evaluation of the Effects of Formulation, Food, or a Proton-Pump Inhibitor on the Pharmacokinetics of Glasdegib (PF-04449913) in Healthy Volunteers: A Randomized Phase I Study
Cancer Chemotherapy and Pharmacology- Germany
doi 10.1007/s00280-018-3748-8
Full Text
Abstract
Available in
Date
December 10, 2018
Authors
Publisher
Springer Science and Business Media LLC